The ingestible biosensors market size has grown rapidly in recent years. It will grow from $1.97 billion in 2025 to $2.18 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to limitations of traditional endoscopy, demand for non invasive diagnostics, advances in miniaturized sensors, rising gastrointestinal disorders, early capsule endoscopy adoption.
The ingestible biosensors market size is expected to see rapid growth in the next few years. It will grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to growth in personalized medicine, integration with mobile health platforms, expanding elderly population, technological improvements in data transmission, increased clinical adoption. Major trends in the forecast period include non invasive gastrointestinal monitoring, smart capsule based diagnostics, real time internal health tracking, personalized digestive health analysis, minimally invasive diagnostic alternatives.
The growing awareness of real-time monitoring is expected to drive the growth of the ingestible biosensors market. Real-time monitoring involves the continuous collection, analysis, and transmission of data as it is generated, enabling immediate health assessment and timely medical intervention. Awareness of real-time monitoring is rising due to the increasing focus on proactive healthcare management, as patients and healthcare providers recognize its value in enabling early detection of health issues and prompt medical responses. Ingestible biosensors facilitate real-time monitoring by transmitting physiological data from inside the body, allowing continuous tracking of parameters such as medication adherence, gastrointestinal activity, and biomarker levels for timely diagnosis and personalized treatment. For example, in October 2024, HealthArc, a US-based healthcare solutions provider, reported that approximately 30 million patients in the U.S. were using remote patient monitoring (RPM), with the number expected to increase to 70.6 million by the end of 2025. Additionally, 42 states have included RPM under Medicaid coverage, and more than 26% of Americans are anticipated to adopt it. Therefore, the increasing awareness of real-time monitoring is fueling the growth of the ingestible biosensors market.
Key companies operating in the ingestible biosensors market are focusing on developing innovative solutions, such as vitals-monitoring pills, to improve real-time health tracking and early disease detection. Vitals-monitoring pills are ingestible electronic capsules that track key physiological parameters, such as heart rate, and transmit real-time health data to external devices for monitoring and analysis. For instance, in November 2023, Celero Solutions Inc., a Canada-based information technology company, developed an ingestible electronic capsule, roughly the size of a multivitamin, capable of measuring heart and breathing rates from within the gastrointestinal tract. In a first-in-human trial involving ten participants, the device reliably detected breathing depressions, such as those occurring in obstructive sleep apnea and potentially in opioid overdose scenarios. The sensor uses an internal accelerometer and wireless transmission to capture vital-sign data and safely passes through the digestive tract without adverse effects. Researchers envision this technology being used for non-intrusive monitoring of respiratory status and potentially triggering interventions in high-risk patients.
In May 2025, imec VZW, a Belgium-based non-profit research and technology organization, partnered with OnePlanet Research Center to advance sustainable technology solutions by leveraging its expertise in nanoelectronics and digital innovations. This collaboration focuses on developing impactful and environmentally responsible healthcare solutions, including ingestible biosensors that enable real-time monitoring of vital signs and gastrointestinal health. OnePlanet Research Center, based in the Netherlands, is a multidisciplinary innovation and research institute specializing in advanced healthcare technologies.
Major companies operating in the ingestible biosensors market are Otsuka Holdings Co. Ltd., Proteus Digital Health Inc., etectRx Inc., CapsoVision Inc., IntroMedic Co. Ltd., BodyCap S.A.S., AnX Robotica Corporation, Atmo Biosciences Pty Ltd., Check-Cap Ltd., Chongqing Jinshan Science & Technology Group Co. Ltd., RF Co. Ltd., Biora Therapeutics Inc., EnteraSense Ltd., Lucid Medical Diagnostics Pvt. Ltd., Medisafe Capsule Technologies Ltd., Medtronic plc, Verily Life Sciences LLC, Olympus Corporation, JIFU Medical Technology Co. Ltd., Smart Medical Systems Ltd.
North America was the largest region in the ingestible biosensors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ingestible biosensors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ingestible biosensors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the ingestible biosensors market by increasing costs for microelectronics, imaging sensors, and wireless communication components. Asia-Pacific manufacturing regions and capsule biosensor segments are most impacted. While tariffs have slightly increased device pricing, they are encouraging localized assembly and innovation in biodegradable and cost-optimized ingestible sensor technologies.
The ingestible biosensors market research report is one of a series of new reports that provides ingestible biosensors market statistics, including ingestible biosensors industry global market size, regional shares, competitors with a ingestible biosensors market share, detailed ingestible biosensors market segments, market trends and opportunities, and any further data you may need to thrive in the ingestible biosensors industry. This ingestible biosensors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ingestible biosensors are advanced medical devices that can be safely swallowed and move through the gastrointestinal tract, where they continuously track physiological parameters such as pH, temperature, pressure, or specific biomarkers. These sensors transmit real-time data to external devices, allowing physicians to evaluate digestive health, identify abnormalities, and tailor personalized treatment plans while reducing reliance on invasive procedures.
The main components of ingestible biosensors include capsule biosensors, pill biosensors, and others. Ingestible biosensors, or capsule biosensors, are swallowable devices equipped with sensors that measure physiological or biochemical conditions inside the gastrointestinal tract and transmit the information for diagnostic or therapeutic use. The various sensor types include temperature sensors, pH sensors, image sensors, and others. They are used in several applications, including medical diagnostics, drug delivery, patient monitoring, sports and fitness, and more, and serve end-users such as hospitals and clinics, research institutes, home care settings, and others.
The ingestible biosensors market consists of sales of ingestible sensor devices, including capsule-based sensors, electronic pills, and smart drug delivery systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The ingestible biosensors market size is expected to see rapid growth in the next few years. It will grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to growth in personalized medicine, integration with mobile health platforms, expanding elderly population, technological improvements in data transmission, increased clinical adoption. Major trends in the forecast period include non invasive gastrointestinal monitoring, smart capsule based diagnostics, real time internal health tracking, personalized digestive health analysis, minimally invasive diagnostic alternatives.
The growing awareness of real-time monitoring is expected to drive the growth of the ingestible biosensors market. Real-time monitoring involves the continuous collection, analysis, and transmission of data as it is generated, enabling immediate health assessment and timely medical intervention. Awareness of real-time monitoring is rising due to the increasing focus on proactive healthcare management, as patients and healthcare providers recognize its value in enabling early detection of health issues and prompt medical responses. Ingestible biosensors facilitate real-time monitoring by transmitting physiological data from inside the body, allowing continuous tracking of parameters such as medication adherence, gastrointestinal activity, and biomarker levels for timely diagnosis and personalized treatment. For example, in October 2024, HealthArc, a US-based healthcare solutions provider, reported that approximately 30 million patients in the U.S. were using remote patient monitoring (RPM), with the number expected to increase to 70.6 million by the end of 2025. Additionally, 42 states have included RPM under Medicaid coverage, and more than 26% of Americans are anticipated to adopt it. Therefore, the increasing awareness of real-time monitoring is fueling the growth of the ingestible biosensors market.
Key companies operating in the ingestible biosensors market are focusing on developing innovative solutions, such as vitals-monitoring pills, to improve real-time health tracking and early disease detection. Vitals-monitoring pills are ingestible electronic capsules that track key physiological parameters, such as heart rate, and transmit real-time health data to external devices for monitoring and analysis. For instance, in November 2023, Celero Solutions Inc., a Canada-based information technology company, developed an ingestible electronic capsule, roughly the size of a multivitamin, capable of measuring heart and breathing rates from within the gastrointestinal tract. In a first-in-human trial involving ten participants, the device reliably detected breathing depressions, such as those occurring in obstructive sleep apnea and potentially in opioid overdose scenarios. The sensor uses an internal accelerometer and wireless transmission to capture vital-sign data and safely passes through the digestive tract without adverse effects. Researchers envision this technology being used for non-intrusive monitoring of respiratory status and potentially triggering interventions in high-risk patients.
In May 2025, imec VZW, a Belgium-based non-profit research and technology organization, partnered with OnePlanet Research Center to advance sustainable technology solutions by leveraging its expertise in nanoelectronics and digital innovations. This collaboration focuses on developing impactful and environmentally responsible healthcare solutions, including ingestible biosensors that enable real-time monitoring of vital signs and gastrointestinal health. OnePlanet Research Center, based in the Netherlands, is a multidisciplinary innovation and research institute specializing in advanced healthcare technologies.
Major companies operating in the ingestible biosensors market are Otsuka Holdings Co. Ltd., Proteus Digital Health Inc., etectRx Inc., CapsoVision Inc., IntroMedic Co. Ltd., BodyCap S.A.S., AnX Robotica Corporation, Atmo Biosciences Pty Ltd., Check-Cap Ltd., Chongqing Jinshan Science & Technology Group Co. Ltd., RF Co. Ltd., Biora Therapeutics Inc., EnteraSense Ltd., Lucid Medical Diagnostics Pvt. Ltd., Medisafe Capsule Technologies Ltd., Medtronic plc, Verily Life Sciences LLC, Olympus Corporation, JIFU Medical Technology Co. Ltd., Smart Medical Systems Ltd.
North America was the largest region in the ingestible biosensors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ingestible biosensors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ingestible biosensors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the ingestible biosensors market by increasing costs for microelectronics, imaging sensors, and wireless communication components. Asia-Pacific manufacturing regions and capsule biosensor segments are most impacted. While tariffs have slightly increased device pricing, they are encouraging localized assembly and innovation in biodegradable and cost-optimized ingestible sensor technologies.
The ingestible biosensors market research report is one of a series of new reports that provides ingestible biosensors market statistics, including ingestible biosensors industry global market size, regional shares, competitors with a ingestible biosensors market share, detailed ingestible biosensors market segments, market trends and opportunities, and any further data you may need to thrive in the ingestible biosensors industry. This ingestible biosensors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ingestible biosensors are advanced medical devices that can be safely swallowed and move through the gastrointestinal tract, where they continuously track physiological parameters such as pH, temperature, pressure, or specific biomarkers. These sensors transmit real-time data to external devices, allowing physicians to evaluate digestive health, identify abnormalities, and tailor personalized treatment plans while reducing reliance on invasive procedures.
The main components of ingestible biosensors include capsule biosensors, pill biosensors, and others. Ingestible biosensors, or capsule biosensors, are swallowable devices equipped with sensors that measure physiological or biochemical conditions inside the gastrointestinal tract and transmit the information for diagnostic or therapeutic use. The various sensor types include temperature sensors, pH sensors, image sensors, and others. They are used in several applications, including medical diagnostics, drug delivery, patient monitoring, sports and fitness, and more, and serve end-users such as hospitals and clinics, research institutes, home care settings, and others.
The ingestible biosensors market consists of sales of ingestible sensor devices, including capsule-based sensors, electronic pills, and smart drug delivery systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Ingestible Biosensors Market Characteristics
3. Ingestible Biosensors Market Supply Chain Analysis
4. Global Ingestible Biosensors Market Trends and Strategies
5. Ingestible Biosensors Market Analysis of End Use Industries
7. Global Ingestible Biosensors Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Ingestible Biosensors Total Addressable Market (TAM) Analysis for the Market
9. Ingestible Biosensors Market Segmentation
10. Ingestible Biosensors Market Regional and Country Analysis
11. Asia-Pacific Ingestible Biosensors Market
12. China Ingestible Biosensors Market
13. India Ingestible Biosensors Market
14. Japan Ingestible Biosensors Market
15. Australia Ingestible Biosensors Market
16. Indonesia Ingestible Biosensors Market
17. South Korea Ingestible Biosensors Market
18. Taiwan Ingestible Biosensors Market
19. South East Asia Ingestible Biosensors Market
20. Western Europe Ingestible Biosensors Market
21. UK Ingestible Biosensors Market
22. Germany Ingestible Biosensors Market
23. France Ingestible Biosensors Market
24. Italy Ingestible Biosensors Market
25. Spain Ingestible Biosensors Market
26. Eastern Europe Ingestible Biosensors Market
27. Russia Ingestible Biosensors Market
28. North America Ingestible Biosensors Market
29. USA Ingestible Biosensors Market
30. Canada Ingestible Biosensors Market
31. South America Ingestible Biosensors Market
32. Brazil Ingestible Biosensors Market
33. Middle East Ingestible Biosensors Market
34. Africa Ingestible Biosensors Market
36. Ingestible Biosensors Market Competitive Landscape and Company Profiles
37. Ingestible Biosensors Market Other Major and Innovative Companies
40. Ingestible Biosensors Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Ingestible Biosensors Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses ingestible biosensors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for ingestible biosensors? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ingestible biosensors market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Capsule Biosensors; Pill Biosensors; Other Product Types2) By Sensor Type: Temperature Sensors; pH Sensors; Image Sensors; Other Sensor Types
3) By Application: Medical Diagnostics; Drug Delivery; Patient Monitoring; Other Applications
4) By End-User: Hospitals And Clinics; Research Institutes; Other End Users
Subsegments:
1) By Capsule Biosensors: Single Sensor Capsule; Multi Sensor Capsule; Smart Capsule2) By Pill Biosensors: Diagnostic Pill; Therapeutic Pill; Monitoring Pill
3) By Other Product Types: Patch Integrated Capsule; Biodegradable Sensor; Wearable Assisted Sensor
Companies Mentioned: Otsuka Holdings Co. Ltd.; Proteus Digital Health Inc.; etectRx Inc.; CapsoVision Inc.; IntroMedic Co. Ltd.; BodyCap S.A.S.; AnX Robotica Corporation; Atmo Biosciences Pty Ltd.; Check-Cap Ltd.; Chongqing Jinshan Science & Technology Group Co. Ltd.; RF Co. Ltd.; Biora Therapeutics Inc.; EnteraSense Ltd.; Lucid Medical Diagnostics Pvt. Ltd.; Medisafe Capsule Technologies Ltd.; Medtronic plc; Verily Life Sciences LLC; Olympus Corporation; JIFU Medical Technology Co. Ltd.; Smart Medical Systems Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Ingestible Biosensors market report include:- Otsuka Holdings Co. Ltd.
- Proteus Digital Health Inc.
- etectRx Inc.
- CapsoVision Inc.
- IntroMedic Co. Ltd.
- BodyCap S.A.S.
- AnX Robotica Corporation
- Atmo Biosciences Pty Ltd.
- Check-Cap Ltd.
- Chongqing Jinshan Science & Technology Group Co. Ltd.
- RF Co. Ltd.
- Biora Therapeutics Inc.
- EnteraSense Ltd.
- Lucid Medical Diagnostics Pvt. Ltd.
- Medisafe Capsule Technologies Ltd.
- Medtronic plc
- Verily Life Sciences LLC
- Olympus Corporation
- JIFU Medical Technology Co. Ltd.
- Smart Medical Systems Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.18 Billion |
| Forecasted Market Value ( USD | $ 3.23 Billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
